Authors: Jarvis, MF Wismer, CT Schweitzer, E Yu, HX van Biesen, T Lynch, KJ Burgard, EC Kowaluk, EA

Citation: Mf. Jarvis et al., Modulation of BzATP and formalin induced nociception: attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X(3) allosteric modulator, cibacron blue, BR J PHARM, 132(1), 2001, pp. 259-269

Authors: Yu, HX Bianchi, B Metzger, R Lynch, KJ Kowaluk, EA Jawis, MF van Biesen, T

Citation: Hx. Yu et al., Lack of specificity of [S-35]-ATP gamma S and [S-35]-ADP beta S as radioligands for ionotropic and metabotropic P2 receptor binding, DRUG DEV R, 48(2), 1999, pp. 84-93

Authors: Alexander, K Niforatos, W Bianchi, B Burgard, EC Lynch, KJ Kowaluk, EA Jarvis, MF van Biesen, T

Citation: K. Alexander et al., Allosteric modulation and accelerated resensitization of human P2X(3) receptors by cibacron blue, J PHARM EXP, 291(3), 1999, pp. 1135-1142

Authors: Jerome, LJ van Biesen, T Frost, LS

Citation: Lj. Jerome et al., Degradation of FinP antisense RNA from F-like plasmids: The RNA-binding protein, FinO, protects FinP from ribonuclease E, J MOL BIOL, 285(4), 1999, pp. 1457-1473

Authors: Bianchi, BR Lynch, KJ Touma, E Niforatos, W Burgard, EC Alexander, KM Park, HS Yu, HX Metzger, R Kowaluk, E Jarvis, MF van Biesen, T

Citation: Br. Bianchi et al., Pharmacological characterization of recombinant human and rat P2X receptorsubtypes, EUR J PHARM, 376(1-2), 1999, pp. 127-138